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Abstract
A decade since the availability of Mycobacterium tuberculosis (Mtb) genome sequence, no promising drug has seen the light
of the day. This not only indicates the challenges in discovering new drugs but also suggests a gap in our current
understanding of Mtb biology. We attempt to bridge this gap by carrying out extensive re-annotation and constructing a
systems level protein interaction map of Mtb with an objective of finding novel drug target candidates. Towards this, we
synergized crowd sourcing and social networking methods through an initiative ‘Connect to Decode’ (C2D) to generate the
first and largest manually curated interactome of Mtb termed ‘interactome pathway’ (IPW), encompassing a total of 1434
proteins connected through 2575 functional relationships. Interactions leading to gene regulation, signal transduction,
metabolism, structural complex formation have been catalogued. In the process, we have functionally annotated 87% of the
Mtb genome in context of gene products. We further combine IPW with STRING based network to report central proteins,
which may be assessed as potential drug targets for development of drugs with least possible side effects. The fact that five
of the 17 predicted drug targets are already experimentally validated either genetically or biochemically lends credence to
our unique approach.
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Introduction
Proclaimed a global health emergency by the World Health
Organization (WHO) in 1993, Tuberculosis (TB) still remains the
leading cause of mortality and affects approximately 32% of the
world population [1]. The emergence of multi-drug-resistant
strains of Mycobacterium tuberculosis, the causative agent of TB, and
the vulnerability of the patients infected with HIV to tuberculosis
have not only fuelled the spread of the disease but also present a
challenging task of understanding the disease physiology and
discovering new drug targets. In this quest, Mtb was sequenced
and annotated in 1998 [2]. A subsequent re-annotation in 2002
successfully assigned functions to almost half of the approximately
4000 genes [3]. More recently, 20 more ORFs have been added to
this list and the annotations updated [4,5]. However a huge gap in
information exists between published literature and the genome
databases. The existing annotations in these databases are thus
insufficient to generate the protein interaction map or the
interactome, pivotal to understanding Mtb biology and identifi-
cation of novel drug targets. To this end, Open Source Drug
Discovery (OSDD) project (www.osdd.net) [6,7] launched the
Connect to Decode (C2D) program (http://c2d.osdd.net), an
innovative blend of crowd sourcing and social networking in a
virtual cloud space for a comprehensive collaborative re-
annotation of Mtb which is the primer for generating the
interactome. The ultimate objective is to identify drug targets
based on better understanding of the complex interactions of
various biological macromolecules in the pathogen.
Systems biology-based approaches have been applied to obtain
better insights into the pathogen biology [8]. This strategy may
help in identifying more than one potential drug targets and these
can be utilized as sets of targets for a polypharmacology approach.
A promising candidate in this category is bi-substrate acyl-
sulfamoyl analogues that simultaneously disrupt crucial nodes in
biosynthetic network of virulent lipid with dramatic effect on the
cell surface architecture of Mtb [9]. Also, a recent study on
genome-wide siRNA experiment has identified host factors that
regulate Mtb load in human macrophages and are crucial to
understand the dynamic interplay of molecular components of the
pathogen and the host [10]. There are many such studies that try
to capture the snapshots of the molecular interactions in Mtb in
different conditions. It is therefore imperative to capture and
curate data on experimentally validated interactions lying
scattered in diverse sources in the literature to generate a genome
scale network. This was achieved through the C2D program. The
C2D community started with initial registration of more than 800
researchers, which largely consisted of research scholars, graduate
students and under-graduate students. The participants were
trained, evaluated and filtered at various stages of online training
and assignments (https://sites.google.com/a/osdd.net/c2d-01/
pathwayannotationproject/results-of-the-exercise). More than
100 researchers were selected as curators to obtain the final
annotations (https://sites.google.com/a/osdd.net/c2d-01/
pathwayannotationproject).
Here we describe how C2D has implemented a community
annotation approach in a distributed co-creation mode for mining
literature and how the accuracies and scope of assigning functions
were enhanced using combined evidence approach. We have
enriched the annotations of the Mtb genome both in terms of
coverage and details (Table 1). Web2.0 collaborative online tools
enabled voluntary community participation for implementing this
task. An important part of the project was creating self-organized
communities to collectively learn and share the process and the
standards for reporting annotations. As per published estimates,
this innovative approach packed nearly 300 man-years into 4
months [11] and it has also established a novel way of collective
problem solving on a voluntary basis in a sustainable manner [12].
This is, to the best of our knowledge, lead to the creation of the
largest manually curated interactome of Mtb. Based on the varied
nature of interactions among proteins in vivo, we propose a new
network definition called ‘‘Protein-Protein Functional Network’’
(PPFN). This network encompasses a total of 1434 proteins
connected through 2575 functional relationships. In this paper, we
detail how the Interactome - PathWay (IPW), an open collabo-
rative platform was used to generate and analyze potential drug
targets. Using betweenness centrality [13] as a first indicator to
shortlist candidate drug targets, we zeroed into 73 proteins. We
have in the process also created a sustainable open innovation
platform.
Results and Discussion
C2D Annotation
An overview of the approach followed in ‘Connect to Decode’
(C2D) exercise is as illustrated in Figure 1. Broadly the approach
was designed based on the principles of the fourth paradigm of
science, encompassing data collation, curation and analysis [14].
Roughly ,4.4 Mbp genome of Mtb was re-annotated manually.
To streamline the annotation process and select a community of
researchers competent to implement this project, a series of online
assignments and training modules were assigned (see methods).
These steps ensured the selection of serious and dedicated
contributors thereby assuring the quality of data collation, curation
and analysis. Various standard operating protocols (SOPs) were
designed and shared with the participants for the consistency in
the steps followed for the annotation of genes (https://sites.google.
com/a/osdd.net/c2d-01/pathwayannotationproject/instructions-
for-annotation and https://sites.google.com/a/osdd.net/c2d-01/
pathwayannotationproject/example-annotation and https://sites.
google.com/a/osdd.net/c2d-01/pathwayannotationproject/steps
forproteinannotation ). Given the exponential increase in the
number of publications from about 300 per year since 1990’s to
a staggering 2000 per year in 2010, the challenging task of
collating and curating data was achieved through the formula-
tion of community editable interactive platform designed to
facilitate real time annotations and continuous updates. The
community scanned and retrieved information from nearly
10,000 published studies in addition to extracting information
from databases and transferred annotations using sequence and
structure analyses based approaches. The community has cited
more than 3000 papers in annotation process as on an average
3–4 manuscripts were referred or read in order to get the
relevant information to annotate a given protein.
The Mtb Genome Annotation and Interactome Curation
IPW has resulted in annotation of 87% of the genome in the
context of reporting gene products as compared to 52% in the re-
annotation reported in 2002. Moreover, less than 5% of the
interactions in IPW (Table S1) exist in other manually curated
interaction databases such as BIND [15], APID [16], IntAct [17],
DIP [18] and MINT [19] (Figure 2(b)). Thus, to the best of our
knowledge, Connect to Decode’s Interactome Pathway Annotation
(IPW) has generated the largest data set of manually curated
interactions in Mtb. These interactions not only include data from
large interaction databases such as IntAct, BIND, MINT, APID,
Crowd Sourcing for M. tuberculosis Interactome
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Table 1. The data structure that was used to capture the interactome data.
Field Description
GeneID The unique identifier for a given gene (Rv ID and NCBI Gene ID)
Gene Name Assigned name of the gene
Pathway Biological role of the gene
Gene function The biological function of the gene
Interacting Partners All the interacting partners for a given gene
Type of Interaction Type of interaction (protein-protein [p-p], protein-nucleotide [p-n])
Nature of Interaction This field contains nature of interaction, such as structural complex, regulatory, signaling etc.
Method of Inferring Interaction Contains information about the experimental or computational methods used for the inference of interacting partners
Type of Evidence Type of evidence, adopted from Gene Ontology (IDA, IPI, ISO, TAS, etc)
PUBMED/Link of source PubMed ID or any web based link from where the interaction and other annotation details were inferred
Email of author E-mail address of curator
There were 11 annotation fields for reporting annotations. The data is available in PSI MITAB format.
doi:10.1371/journal.pone.0039808.t001
Figure 1. From Social Network to Biological Network. The C2D annotation approach for manual annotation and curation of Mtb interactome
followed by network analysis to predict potential drug targets reported at various sequence and structural level filters. (A) Illustrates the overall
approach of crowd sourcing through social network implemented in C2D exercise (B)(a) Mtb Genome (b) Manual collation and sequence/structure
based curation for gene annotation (c) Collation of re-annotated genome into comprehensive data structure (d) Construction of protein-protein
interaction network based on the annotated data (e) Target identification using network analysis; Sequence level comparison of selected proteins
with that of human homologs, human gut flora and human oral flora; systems, sequence and structure level analysis of shortlisted proteins and
experimentally validated drug targets.
doi:10.1371/journal.pone.0039808.g001
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DIP, etc but also include a large amount of manually curated
information from literature.
Of the 1193 hypothetical proteins from TubercuList [4], the
IPW based annotations identify gene products for 770 proteins. Of
the 1480 hypothetical proteins reported in KEGG [20] database,
functional associations have been made to 1055 proteins, clearly
showing how IPW has bridged the wide gap that existed between
information captured in databases and that available in literature.
To ensure that IPW remains up to date, the data from IPW is
shared with members of the OSDD community in an ‘edit’ mode,
through which new interactions can be added using the SOP that
includes a rigorous quality check phase, specifically designed for
community contribution.
Interactome Construction: IPW and Combined Network
with STRING
Interactome as a whole constitutes various biological interac-
tions belonging to both structural and functional type of protein-
protein associations. To have an encyclopedic view of various
interactions that take place at protein functional level, we report
the construction of two types of networks. The first network,
termed IPW only (Figure 2(a)), was constructed on the basis of
the IPW curated data alone. The nodes in the network represent
the proteins whereas the edges represent the functional interac-
tions among those proteins. The nodes were scaled and color
coded in proportion to their degrees. Also, based on the common
interactions we derived a connectivity relationship between
various TubercuList functional classes [4]. Figure 2(c) shows
the connectivity among 10 broad functional classes of Tubercu-
List. The edge thickness was taken to be directly proportional to
the number of common proteins between the two TubercuList
functional classes for the given pair. Significant functional
dependencies are seen among the ‘Lipid Metabolism, Cell Wall,
Intermediary metabolism and Regulatory systems’ functional
classes, reflected in their edge thicknesses in the network.
Disruption of such linkages can lead to breakdown of crosstalk
between these biological processes and thus could be exploited to
identify new drug targets.
Secondly, in order to obtain insights on the complete functional
organization among all the possible proteins of Mtb, a combined
network termed, IPW-STRING (IPWSI), was constructed by
overlaying STRING network on the IPW network. The STRING
based network of Mtb was derived from STRING 8.0 [21]
database consisting of various interactions among proteins as
derived on the basis of extensive computational and limited
experimentally inferred interactions. Computational predictions
Figure 2. IPW interactome and comparison with existing annotation databases (a) IPW-Only protein-protein functional interaction network, (b)
Comparative analysis of IPW-Only proteins and interaction with existing manually curated databases, Ring represents all interactions and proteins in
IPW displaying the subsets which are obtained from other manually curated databases (b1) Comparative analysis of IPW-Only interactions to that of
existing manually curated databases (b2) comparative analysis of protein as curated in IPW-Only to that of proteins presents in other manually
curated databases (c) TubercuList functional class interaction relation based on the interactions as obtained from IPW-Only. The connectivity (lines)
represents the interacting proteins within these classes.
doi:10.1371/journal.pone.0039808.g002
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have been based on established methods such as phylogenetic
profiling, domain fusion, common gene neighborhood and operon
criteria. However, computational models over predicts interactions
since they do not account for spatio-temporal separation of the
interacting partners. Thus, in the combined network the accuracy
of interaction decreases whereas the coverage increases. It should
also be noted that there is an inherent bias for well-studied proteins
in IPW. A simple comparison shows that nearly 60% of IPW
interactions have experimental evidence codes as compared to 2%
existing in STRING. Also, about 29 additional proteins and 1762
new functional interactions apart from that reported by STRING
were included in the new IPW-STRING combined interactome.
The combined IPW-STRING interactome was further used to
decipher various possible drug targets using the concepts of graph
theory. The network analysis of these networks provides a means
to understand the functional organization of the organism from
the network topology point of view [22,23]. Various network
properties as computed for both the networks and their biological
relevance are discussed below.
Topological Organization of Interactome
In order to understand the functional organization of con-
structed interactome we further assessed the fundamental prop-
erties of this network from the graph theoretic point of view. Given
a vast interaction space encompassing the interactome as whole,
where the nodes represents proteins and interaction represents a
functional relation between them, it becomes imperative to
understand the functional organization of the network from its
topology. The most fundamental characteristic of a graph is the
connectivity of its constituent nodes as represented by the degree.
Degree, being a measure of interconnectedness of nodes highlight
the importance of a node (protein in this case) with respected to
other nodes in the network. A maximum degree of 44 and 289 was
observed for the IPW and IPWSI networks, respectively,
suggesting the level of maximum number of functional relation
of a given protein in both the networks.
Clustering coefficient for a node indicates the connectivity of
the neighbours of a given node to the other nodes in the network
[24]. This parameter was computed to elucidate the dependen-
cies of two or more proteins with respect to each other and to
rest of the proteins in the network. The clustering coefficient for
Figure 3. Network parameters (a) Characteristic path length of IPW-Only network and IPWSI network. In both the graphs the x-axis represents the
path length whereas the y-axis represents the frequency. 3(b) Log-Log plot of degree distribution of IPW network, the solid line was obtained by
fitting the power law for c =1.99 and Log-Log plot of degree distribution of IPWSI network, the solid line represents the power law fit with c = 2.01.
doi:10.1371/journal.pone.0039808.g003
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IPW and IPWSI networks was observed to be 0.249 and 0.377,
respectively. The high clustering coefficient of both the networks
suggests the presence of well-connected hubs within the network,
which are important from the functional crosstalk between the
proteins of Mtb. Further, the characteristic path length of both
the networks was computed in order to comprehend the extent
of functional relation between any two given proteins in the
network. The characteristic path length of both the networks is
as shown in Figure 3(a). The characteristic path length in IPW
network was observed to be 7.2 whereas for IPWSI it was
observed to be 3.13. From the network navigability point of view
the characteristic path length can be inferred as the number of
steps that one has to take traversing from one node to other,
which from biological point of view could be inferred as the
amount of communication that is possible between any two
proteins. Pertaining to the high characteristic path length of IPW
alone, the absence of functional relation between any two
proteins can be inferred; however, the functional relation
between any two proteins increase when the IPW alone was
clubbed with STRING based network. The characteristic path
length, thus, can be used to understand the functional gap that
possibly exists in the protein-protein interaction network.
Emphasizing on the network communication further, the
network diameter was computed representing the length of the
‘longest’ shortest path in the network. The network diameter of
IPW and IPWSI networks was observed to be 18 and 10,
respectively. Akin to characteristic path length, the network
diameter can be used to interpret the overall navigability of the
network, the higher the diameter, the more distantly two nodes
are related and vice versa.
As discussed, understanding the topological organization of the
network could lead to better understanding of its underlying
principles. The network topology could also be used to
understand the number of possible modules (hubs) in the
network, which may help in identifying potential drug targets.
In order to obtain such insights, we tested the existence of power
law distribution on IPW and IPWSI networks, respectively. The
power law distribution can also be used to understand the scale
free nature of a network [23]. There is extensive literature that
reports the existence of scale free nature of biological networks.
The power law distribution on the node degree distribution of
IPW and IPWSI networks is shown in Figure 3(b). The value
of c was observed to be 1.99 for IPW and 2.01 for IPW-
STRING combined node degree distribution.
Target Identification
Apart from inferring fundamental principles of network
properties the availability of an interactome also enables predic-
tion of essential proteins from the network structure point of view.
The protein lethality within a network is usually obtained from the
degree distribution of the nodes in the networks. The nodes with
high degree are considered important and hence regarded as
probable drug targets. The degree distribution alone could lead to
improper putative drug target identification as it does not capture
the alternate routes in the network. Most of the biological networks
possess large number of shortest paths [25]. The large number of
shortest paths also suggests the availability of alternate routes
within the network which could be used to achieve a certain
biological objective. Removing such nodes from the network could
lead to maximum disruption in the network. In order to capture
these properties, important nodes as well as important edges, we
used betweenness centrality [24,26] as a metric system to infer
putative drug targets. The node betweenness centrality at a
threshold of $0.2 lead to identification of 17 and 64 central
proteins from IPW and IPWSI networks, respectively (Table S2).
Analysis of Putative Drug Targets: Identifying Probable
Non-toxic Targets
To design a viable drug it is essential to ensure least probability
of off-target interactions. A sequence, structure and systems based
analysis was performed in order to predict the druggability of the
shortlisted central proteins from the two networks so as to reduce
the chances of off-target interactions.
The list of 17 and 64 proteins (73 unique proteins as eight are
common in the two lists) was first filtered against human homologs
and human oral and gut flora [27]. Of the 17 targets identified by
IPW, none had a homolog in human proteome and in human oral
and gut flora. In the combined network IPWSI, 53 such targets
were identified (Figure 4). There are 62 unique central proteins
without any significant homology to human proteome, gut and
oral flora from IPW and IPWSI. We further analyzed this list of 62
proteins for absence of small peptides (octamer) since it has been
reported that a small fraction of peptide sequences are evolution-
arily conserved and invariant across several organisms [28]. These
peptide sequences can adopt similar conformation in different
protein structures [28]. A comparative analysis shows that one
protein Rv3221A does not share any common octapeptide with
human proteome, gut or oral flora. However, a closer and detailed
analysis needs to be performed for proteins sharing octapeptide
with human proteome and human microbiome in order to
evaluate their status for off-target binding. In order to understand
the binding pockets, an independent analysis has been performed
to predict and match binding pockets of central proteins with
human proteome. Of the 73 central proteins, 57 have either PDB
or ModBase [29] structure making them amenable to structural
analysis for druggability. We analyzed these proteins as per the
targetTB [30] pipeline where the top 10 binding sites for each of
these 57 proteins were identified using PocketDepth algorithm
[31]. The binding pockets of these proteins were then compared
with human proteome using PocketMatch [32]. Of the 57
proteins, 31 proteins have high structural similarity with human
proteome at binding site level whereas 26 proteins which do not
have binding site similarity with human proteome. It is interesting
to note that seven of these are experimentally validated drug
targets.
Rv3221A (RshA) (Figure 4 List d), an anti-sigma factor to the
primary stress response sigma factor SigH, passed all filters but is
neither reported as a potential drug target in literature nor in
targetTB predictions. The gene encoding RshA lies in the same
operon as SigH and is co-expressed with the same [33]. It has a
strong affinity to bind with SigH and attenuates its ability to bind
to the RNA polymerase holoenzyme under normal growth
conditions. Under conditions of oxidative stress, phosphorylation
of RshA by Rv0014c (PknB) abolishes its binding to SigH, which
in turn leads to the cascade of expression of several stress response
proteins [34] (Figure 5). SigH causes increased expression of two
other sigma factors Rv2710 (SigB) and Rv1221 (SigE), which are
also known to be stress related sigma factors that assist Mtb in its
survival during several stress conditions and are also central
proteins. The other interacting partners of RshA include heat
shock proteins and chaperones like Rv0384c (ClpB) and Rv0350
(DnaK), enzymes for oxidative stress response Rv1471 (TrxB1),
Rv3913 (TrxB2) and Rv3914 (TrxC) which are also part of the
sigH regulon. sigH also induces enzymes involved in cysteine
biosynthesis and in the metabolism of ribose and glucose for the
production of mycothiol precursors, which assist in cellular
protection under oxidative stress. The SigB and SigE signaling
Crowd Sourcing for M. tuberculosis Interactome
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cascade downstream interacts and regulate other central proteins
(Figure 5). RshA is at the beginning of this cascade and seems to
play in crucial role in regulating the stress response proteins,
starting with sigH.
The objective of the interactome construction and analyses
was to identify central proteins, which have significant roles in
maintaining growth and survival of the bacterial pathogen. We
identified 17 such central proteins (Table 2), five of which (PknB,
NuoG, PhoP, EccCb1, HspX) have been previously functionally
characterized and shown to be essential by gene deletion and
mutation and thus are considered as validated drug targets. The
target gets further validated if there are inhibitors which inhibit
the function of the target enzyme or protein as well. PknB
(Rv0014c) is an essential serine-threonine protein kinase in Mtb
and has role in a number of signaling pathways in cell division
and metabolism. Several inhibitors have been reported for this
kinase [35] and is also one of the targets being pursued by
Working Group on New TB Drugs (http://www.newtbdrugs.
org/project.php?id = 81). NuoG (Rv3151) is a subunit of type I
NADH dehydrogenase playing an important role in growth in
macrophage and pathogenesis in animal models [36]. PhoP
(Rv0757), a response regulator and part of the two component
system, when mutated leads to growth defects in macrophages
and in mouse models [37]. eccCb1 (Rv3871) is a part of the RD1
Figure 4. Illustrates the comprehensive analyses of central proteins as potential drug targets. The various filters include comparison with
validated drug targets, sequence and structural level comparison with Human proteome, gut and oral flora (a) The list of 73 central ORFs wherein Rv
Ids in bold represent IPW central ORFs, Rv IDs in regular font represents IPWSI central ORFs and the italicized-bold represent common Rv Ids to both
IPW and IPWSI. (b & b’) Five of the 17 IPW and six of 64 central ORFs with experimental validation as drug targets. (c) Sequence homology comparison
with human proteome and human microbiome results in 62 ORFs with no significant similarity (d) Octamer analyses against human proteome and
human microbiome results in one ORF with no hits (e) Comparative binding site analysis with human proteome results in 26 ORFs with no significant
similarity (lists b, b’, c, d and e available in Table S2).
doi:10.1371/journal.pone.0039808.g004
Crowd Sourcing for M. tuberculosis Interactome
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region and mutation leads to attenuated growth and toxicity in
THP-1 cells. The mutants cannot export CFP-10 and are
avirulent [38]. hspX (Rv2031c) encodes for a alpha-crystallin-like
protein and plays a significant role in retaining a non-replicating
state in latency [39,40]. The fact that five of the 17 putative drug
targets from IPW are already validated drug targets, lends
credence to our approach of annotating the genome and
interactome construction of Mtb for system level understanding
towards novel drug target identification.
Despite the efforts over a number of years, discovering novel,
fast acting drugs for TB has been a major challenge. However,
recently introduced combination drug Risorine designed on the
principles of Ayurveda has been shown to cut down rifampicin use
leading to very high compliance [41]. Understanding the biology
of the pathogen through a systems level approach can help in
identifying the Achilles heel for Mtb. Towards this, Interactome
Pathway annotation has captured the updated relevant informa-
tion on Mtb genes and has tried to unravel the puzzle. We have
amalgamated crowd sourcing with social networking to compre-
hensively reannotate the Mtb genome, generated its largest ever
interactome and propose potentially efficacious drug targets. In
the process, we have set up an open collaborative platform and a
dynamic community to ensure regular updates.
Materials and Methods
Crowd Sourcing for Data Curation
Data capture. Two annotation standard operating protocols
(SOPs), in the presence of literature and in the absence of
literature, were designed in order to capture the maximum
amount of relevant data. Wherever the protein was not studied in
Mtb, the annotations were transferred from other organisms based
on conservative statistical measures in sequence and structure-
based analysis as discussed below (i and ii). To ensure consistency
and integrity of the data added to the resource, Standard
Operating Protocols (SOPs) were created and followed by the
community. These SOPs and tutorials may be accessed at (http://
c2d.osdd.net and https://sites.google.com/a/osdd.net/c2d-01/
pathwayannotationproject).
Annotation SOP in presence of literature. The first step
was to retrieve information on Mtb proteins with experimental
evidence from literature. PubMed and Google based literature
searches were carried out using suitable keywords, such as the
respective Rv number, gene name, Mycobacterium tuberculosis, along
with suitable Boolean expressions, such as AND and OR (for
example, [Rv1018c] AND [mycobacterium tuberculosis], [epox-
ide hydrolase] AND [mycobacterium tuberculosis]). While
Figure 5. Illustration of 17 putative drug target interaction from IPW interactome depicting the cascade of how the central proteins
interact with each other in a spatio-temporal manner under different conditions like growth, stress and survival in macrophages
including virulence. Under normal conditions, PknB phosphorylates RshA which inhibits SigH. However, under oxidative stress, RshA is not
phosphorylated and this abolishes its binding to SigH, rendering it free. SigH in turn upregulates expression of SigE and SigB which regulates MprA
(bacterial persistence regulator). MprA also regulates SigB and SigE. SigB plays important role in adaptation to stationary phase and nutritionally poor
conditions and SigE is upregulated in mycobacterial growth within human macrophages and is transcribed from three different promoters under
different conditions. sigB is also regulated by SigF, which regulates the expression of genes involved in the biosynthesis and structure of the
mycobacterial cell envelope, including complex polysaccharides and lipids, particularly virulence- related sulfolipids and several transcription factors.
Rv0516c is an anti-anti sigma factor and regulates anti-sigma factor SigF (upregulated during infection culture of human macrophages and in
nutrient starvation condition; regulates transcription of genes involved in cell wall biosynthesis, sulfolipid metabolism, nucleotide metabolism, energy
metabolism and several transcription factors) on getting phosphorylated by PknD which in turn is regulated by Rv0020c phosphorylated by PknB and
PknE. SigF also regulates sigC and regulates hspx that is also regulated by dosR regulon. dosR regulon in turn is again regulated by PhoP which is a
transcription factor for nuoG, eccCb1, esxb/cfp10 [48].
doi:10.1371/journal.pone.0039808.g005
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manually scanning the available literature, emphasis was placed
on the references, which dealt with Mycobacterium tuberculosis
H37Rv followed, by evidence in other mycobacterial species. If
the protein was an enzyme, the corresponding reaction, along
with the EC number, and the pathway(s) in which the protein
participates was also recorded.
SOP for annotation in the absence of direct information
from literature. In absence of direct literature information,
annotations were derived based on sequence, structure and profile
based information and analyses. To begin with, NCBI-BLAST
[42] was used to obtain homology information of the query
protein. Hits with e-value of #0.0001 and identity of $35%, with
$75% sequence coverage were considered as significant hits.
Annotations of the closest homologue were transferred and
recorded in the template against each annotation. Similarity
search in the Pfam [43] database was carried out to support
BLAST results and also to annotate in the absence of high query
coverage with BLAST analysis. If both BLAST and Pfam
similarity search failed to give a significant hit, Phyre [44], an
automatic fold recognition tool was used for predicting the
function of the Mtb proteins through high confidence fold
associations. Appropriate evidence codes have been used to
distinguish between transferred annotations and experimental
based annotations.
Data curation. Multiple rounds of collaborative data quality
checks were carried out to ensure that the data has been correctly
captured and reported. A set of instructions (SOPs) were devised
for the same (https://sites.google.com/a/osdd.net/c2d-01/
pathwayannotationproject/data-qc-guide) where the annotations
curated by the members were systematically crosschecked
iteratively by other members. It was interesting to note that high
quality curation was achieved by this approach of ‘many eyeballs
make the bug shallow’, a common phenomenon in open source
software projects.
Data organization. The collated data was organized into a
defined data structure as depicted in Table 1 with two columns,
field and description. The PSI MI (Proteomics Standards Initiative
Molecular Interactions) was used as the community standard for
reporting protein-protein interactions in MITAB format (Table
S3). This helps in improving the representation of molecular
interaction data and its accessibility to the user community.
Interactome Construction and Network Parameter
Estimation
IPW and IPWSI network. The IPW-only network was
constructed based on the annotations and curation of the data
from IPW. The combined network of IPW and STRING termed,
IPWSI, was constructed by combining the IPW network with that
from STRING. All the interactions in STRING with high and
medium level confidence score (above 400) were used to construct
STRING based protein-protein interaction network. Methods
used to compute network parameters are discussed below.
Network properties. To understand the functional organi-
zation of interacting proteins in both the networks, an analysis of
various network topologies was performed. These network
properties were computed using Boost Graph library in MATLAB
(David Gleich; http://www.stanford.edu/,dgleich/programs/
matlab_bgl/).
Connectivity or degree. The most elementary characteristic
of a node in the network is its degree k, which represents, for a
given node the number of other nodes it is connected to.
Clustering coefficient. The clustering coefficient was first
defined by Watts and Strogatz [24]. The clustering coefficient, C,
for a node is a notion of how connected the neighbours of a given
node are to the other nodes (cliquishness) [45]. The average
clustering coefficient for all nodes in a network is taken to be the
network clustering coefficient. In an undirected graph, if a vertex vi
has ki neighbors, k i (k i - 1)/2 edges could exist among the vertices
Table 2. The list of all the 17 central proteins as predicted from the betweenness centrality of .0.2 through IPW network with
their gene products.
Accession Gene Name Description (Gene Product)
Rv0014c*[35] pknB TRANSMEMBRANE SERINE/THREONINE-PROTEIN KINASE B PKNB (PROTEIN KINASE B)
Rv0020c fhaA CONSERVED HYPOTHETICAL PROTEIN WITH FHA DOMAIN, TB39.8
Rv0516c Rv0516c ANTI-ANTI SIGMA FACTOR
Rv0757*[37] phoP POSSIBLE TWO COMPONENT SYSTEM RESPONSE TRANSCRIPTIONAL POSITIVE REGULATOR
Rv0931c pknD TRANSMEMBRANE SERINE/THREONINE-PROTEIN KINASE D PKND (PROTEIN KINASE D)
Rv0981 mprA MYCOBACTERIAL PERSISTENCE REGULATOR MRPA (TWO COMPONENT RESPONSE TRANSCRIPTIONAL REGULATORY PROTEIN)
Rv1221 sigE ALTERNATIVE RNA POLYMERASE SIGMA FACTOR SIGE
Rv2031c*[39,40] hspX HEAT SHOCK PROTEIN HSPX (ALPHA-CRSTALLIN HOMOLOG) (14 kDa ANTIGEN) (HSP16.3)
Rv2069 sigC PROBABLE RNA POLYMERASE SIGMA FACTOR, ECF SUBFAMILY
Rv2710 sigB RNA POLYMERASE SIGMA FACTOR
Rv3151*[36] nuoG PROBABLE NADH DEHYDROGENASE I (CHAIN G) NUOG (NADH-UBIQUINONE OXIDOREDUCTASE CHAIN G)
Rv3221A Rv3221A POSSIBLE ANTI-SIGMA FACTOR RSHA
Rv3223c sigH ALTERNATIVE RNA POLYMERASE SIGMA-E FACTOR (SIGMA-24)
Rv3286c sigF ALTERNATE RNA POLYMERASE SIGMA FACTOR
Rv3871*[38] Rv3871 ESX CONSERVED COMPONENT ECCCB1 (ATPase activity)
Rv3874 esxB 10 KDA CULTURE FILTRATE ANTIGEN ESXB (LHP) (CFP10)
Rv3911 sigM RNA POLYMERASE SIGMA FACTOR
RvIDs superscripted with asterisk are essential proteins as evidenced by genetic and biochemical studies.
doi:10.1371/journal.pone.0039808.t002
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within the neighbourhood (Ni ). The clustering coefficient for an
undirected graph G(V, E) (where V represents the set of vertices in
the graph G and E represents the set of edges) can then be
defined as
Ci~
2D ejk
 
D
ki ki{1ð Þ ; vj ,vk[Ni,ejk[E
The average clustering coefficient characterizes the overall
tendency of nodes to form clusters or groups. C(k) is defined as the
average clustering coefficient for all nodes with k links.
Characteristic path length. The characteristic path length,
L, is defined as the number of edges in the shortest path between
two vertices, averaged over all pairs of vertices. It measures the
typical separation between two vertices in the network. Intuitively,
it represents the network’s overall navigability [45].
Network diameter. The network diameter d is the greatest
distance (shortest path, or geodesic path) between any two nodes in
a network. It can also be viewed as the length of the ‘longest’
shortest path in the network.
d~max
u,v[G
dG u, vð Þ
where dG (u, v) is the shortest path between u and v in G [45].
Power law distribution. For a given network the power law
distribution states the probability that a given node has k links,
which is given by equation p(k) , k-c, where c is degree exponent.
For smaller values of c, the role of the ‘hubs’, or highly connected
nodes, in the network becomes more important. For c .3, hubs
are not relevant, while for 2,c ,3, there is a hierarchy of hubs,
with the most connected hub being in contact with a small fraction
of all nodes. Scale-free networks have a high degree of robustness
against random node failures, although they are sensitive to the
failure of hubs [23]. The probability that a node is highly
connected is statistically more significant than in a random graph
[45].
Betweenness centrality. The betweenness centrality is the
measure of vertex within a graph. For a given graph G(V,E), with
n vertices, the betweenness CB (v) of a vertex v is defined as.
CB vð Þ~
X
s=v=t [V
sst(v)
sst
where sst is the number of shortest path from s to t, and sst (v) is
the number of shortest paths from s to t that passes from vertex v.
The betweenness centrality analysis was performed for both the
networks [45–46].
Drug Target Identification
Sequence homology with human proteome, oral and gut
flora. The complete human proteome was downloaded from
NCBI and BLAST was used to filter out the proteins, which had
homology of greater than 45% with human protein. Human gut
and oral flora constitutes the microbes that are considered to
influence the physiology, nutrition, immunity and development of
host. The complete proteome of 8-gut flora and 27 oral floras were
downloaded. CD-HIT with similarity of 60% and a word size of 4
was used to compare the predicted proteins [27].
Binding site similarity with human proteome, oral and
gut flora. We analyzed these proteins as reported in targetTB
[30] pipeline where the top 10 binding sites for each protein was
identified using PocketDepth algorithm [31]. The binding pockets
of these proteins were then compared with human proteome using
PocketMatch [32].
Peptide level conformation comparison with human
proteome, oral and gut flora. We analyzed the proteins for
absence of small peptides (octamer) [28] across human proteome,
gut or oral flora using in house PERL scripts.
Literature based target validation. The predicted targets
were further validated based on presence of existing functional
evidence in literature. Data-mining and manual curation was
performed to identify and document validated drug targets in Mtb.
In addition to this, it was also documented whether the central
protein is also reported to be essential or non-essential in context of
Mtb growth and survival.
Web Server for Accessing and Searching IPW
The IPW data has been posted on http://sysborg2.osdd.net, the
semantic web-based platform of Open Source Drug Discovery
(OSDD) project [47]. For ease of access and search, the data is
provided through a web-based server available at http://crdd.
osdd.net/servers/ipw built using PHP and Mysql. This also works
as the annotation and curation interface for the community. Any
new submission to this web servers requires http://sysborg2.osdd.
net open ID for authentication so that appropriate credits may be
given to the members submitting updated information.
Supporting Information
Table S1 The annotations in the data structure format
described in Table 1. This data may be searched in customized
manner using the IPW web-interface (http://crdd.osdd.net/
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Table S2 Rv Ids in lists b, b’, c, d and e as obtained
from various sequence and structural level analysis of
central proteins as potential drug targets from IPW and
IPWSI as depicted in Figure 2.
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Table S3 Central proteins predicted from analysis of
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